News
-
-
COMMUNIQUÉ DE PRESSE
MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
MindBio Therapeutics Corp. has received regulatory approval for clinical trials using MB22001 to address PMS and PMDD in menstruating individuals. The trials aim to assess the drug's mood-related effects during different menstrual phases -
-
COMMUNIQUÉ DE PRESSE
Reggora Partners With Loan Originator Networks to Automate Appraisal Order Compliance From Wholesale Brokers and Non Delegated Correspondents
Reggora partners with Loan Originator Networks to ensure appraisal orders from third-party brokers comply with updated appraiser independence requirements, improving efficiency and borrower experience -
-
-
-
COMMUNIQUÉ DE PRESSE
CRCAM Alpes Provence : Avis financier au 31 mars 2024
Le Crédit Agricole Alpes Provence affiche des résultats financiers solides au 31 mars 2024, confirmant son engagement envers ses clients et la société. Une croissance maîtrisée et des perspectives de développement encourageantes -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: KWS SAAT SE & Co. KGaA: Preliminary figures show significant growth in sales and EBIT for first nine months 2023/2024 – full-year forecasts raised
KWS SAAT SE & Co. KGaA reports significant sales and EBIT growth in the first nine months of 2023/2024, with raised full-year forecasts -
COMMUNIQUÉ DE PRESSE
TUI AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
TUI AG announces the upcoming disclosure of its half-year/Q2 financial report for 2023 in German and English on May 15, 2024. Find more information on their investor relations page
